Highlights
Mid-term review sets future direction
A comprehensive independent assessment found the Centre to be performing at a high level, producing distinct and positive ben...
read the full story
Smarter drug design
An advanced experimental technique linked to high powered computation is becoming an increasingly important tool for MWC rese...
read the full story
MWC welcomes landmark results for lung cancer drug
A novel lung cancer drug with strong development links to the MWC has shown impressive results in a large-scale international...
read the full story
Newly funded research highlights MWC collaborations
A five-year research programme aims to develop nontoxic vaccine technologies to complement existing cancer immunotherapies.
read the full story
The tumour-promoting activities of a famous protein
Developing new cancer therapies and a more reliable test for prostate cancer are just some of the potential outcomes of Mauri...
read the full story
MWC leads cancer immune therapy conversation
The Maurice Wilkins Centre continues to be part of an international drive to develop and improve immune therapy for cancer. I...
read the full story
Cancer drug advances to phase II clinical trials
A New Zealand cancer drug developed by two Maurice Wilkins Centre investigators has reached the second phase of clinical tria...
read the full story
New therapies - from a new generation (2013)
Nurturing the next generation of scientists is an important part of the Maurice Wilkins Centre’s work – and senior students c...
read the full story
New chemistry transforms cancer vaccine (2013)
A new kind of chemistry that dramatically simplifies the manufacture of cancer vaccines was created this year by Honours stud...
read the full story